Literature DB >> 31935299

Impact of Drusen Burden on Incidence of Subclinical CNV With OCTA.

Atsuro Uchida, Sunil K Srivastava, Deepa Manjunath, Rishi P Singh, Aleksandra V Rachitskaya, Peter K Kaiser, Jamie L Reese, Justis P Ehlers.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the impact of drusen burden on the detection of subclinical choroidal neovascularization (CNV) on optical coherence tomography angiography (OCTA) in nonexudative age-related macular degeneration (AMD). PATIENTS AND METHODS: A subanalysis of the AVATAR study, subjects diagnosed with nonexudative AMD without subfoveal atrophy were included. Subclinical CNV was assessed using OCTA software, and drusen burden was graded utilizing the advanced retinal pigment epithelium (RPE) analysis.
RESULTS: Among eligible 58 eyes, 26 eyes (45%) had high drusen burden. Of the three eyes (5%) that demonstrated subclinical CNV, only one eye had high drusen burden, and all three eyes had neovascular AMD in the fellow eye. Extrafoveal RPE atrophy (odds ratio [OR] = 20.0; 95% confidence interval [CI], 1.53-261) and older age (OR = 1.27; 95% CI, 1.01-1.59) were predictive factors for subclinical CNV.
CONCLUSION: Extrafoveal RPE atrophy, older age, and fellow-eye CNV were significant risk factors for underlying subclinical CNV in nonexudative AMD. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:22-30.]. Copyright 2019, SLACK Incorporated.

Entities:  

Year:  2019        PMID: 31935299     DOI: 10.3928/23258160-20191211-03

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

Review 1.  Reverse Cholesterol Transport Pathway and Cholesterol Efflux in Diabetic Retinopathy.

Authors:  Xinyuan Zhang; Kaiyue Wang; Ling Zhu; Qiyun Wang
Journal:  J Diabetes Res       Date:  2021-10-26       Impact factor: 4.011

Review 2.  Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD).

Authors:  Vivian Paraskevi Douglas; Itika Garg; Konstantinos A A Douglas; John B Miller
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.